Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    -0.05 (-2.86%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Statement re Shareholder Support

28 Apr 2021 16:22

RNS Number : 9593W
Globalworth Real Estate Inv Ltd
28 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

28 April 2021

Globalworth Real Estate Investments Limited ("Globalworth" or the "Company")

Growthpoint, EBRD and Oak Hill agree Offer significantly undervalues Globalworth

Globalworth notes the announcements by Growthpoint Properties Limited ("Growthpoint"), The European Bank for Reconstruction and Development ("EBRD") and Oak Hill Advisors ("OHA"), responding to the unilateral announcement by CPI Property Group S.A. and Aroundtown SA of a firm intention to make a cash offer for the share capital of Globalworth (the "Offer").

On 26 April, a committee of the Globalworth board comprising independent directors (the "Independent Committee") announced that the Offer significantly undervalues the Company, its assets and its prospects.

The Independent Committee refers to the statement by the Growthpoint Board that they "agree with the assessment of value by the Globalworth Independent Committee", by EBRD that the offer "undervalues the Company, its assets and its prospects" and by OHA that it "currently intends to take no action in respect of the Offer given that OHA also believes that it undervalues the Company".

The Independent Committee values the opinion and collective support of Growthpoint, EBRD and OHA, being shareholders who together hold 39.8% of the entire issued share capital of the Company and represent 82.0% of the Globalworth shareholders to whom the Offer would be made.

 

Enquiries:

 

Globalworth

Via advisers

Geoff Miller, Chair of the Board

 

 

 

J.P. Morgan Cazenove (Financial Adviser)

Tel: +44 20 7742 4000

Massimo Saletti / Leon Li

Dwayne Lysaght / Jonty Edwards

 

 

 

Jefferies (Joint Broker)

Tel: +44 20 7029 8000

Stuart Klein

 

 

 

Panmure Gordon (Nominated Adviser and Joint Broker)

Tel: +44 20 7886 2500

Dominic Morley / Alina Vaskina

 

 

Important notices

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

Disclaimer

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.globalworth.com, by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Appendix

Sources of Information and Bases of Calculation

The figures presented in this announcement are based upon:

· 221,118,513 Globalworth shares in issue as per the Rule 2.9 disclosure on 14 April 2021

· 113,879,464 Globalworth shares held by CPI Property Group S.A. and Aroundtown SA as per the Rule 2.7 announcement on 14 April 2021, representing in aggregate approximately 51.50 per cent. of the existing issued share capital of Globalworth. This excludes the warrants over a further 2,830,020 Globalworth shares which will lapse in accordance with their terms should the Offer be declared unconditional in all respects

· 65,238,742 Globalworth shares held by Growthpoint as per the Rule 8.3 disclosure on 27 April 2021, representing in aggregate approximately 29.50 per cent. of the existing issued share capital of Globalworth

· 11,064,966 Globalworth shares held by EBRD as per the Rule 8.3 disclosure on 27 April 2021, representing in aggregate approximately 5.00 per cent. of the existing issued share capital of Globalworth

· 11,665,106 Globalworth shares held by OHA as per the Rule 8.3 disclosure on 28 April 2021, representing in aggregate approximately 5.28 per cent. of the existing issued share capital of Globalworth

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDKFBDPBKDCQB
Date   Source Headline
3rd Jun 20263:11 pmRNSFitch investment grade credit rating maintained
22nd May 202611:39 amRNSSatisfaction of employee share awards and TVR
15th May 20267:00 amRNSNotice of AGM and Availability of Annual Report
24th Apr 20265:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20267:00 amRNSAudited Results FY25, Annual Report, Notice of AGM
26th Mar 20261:00 pmRNSS&P - 'BB' Rating affirmed
19th Mar 20267:00 amRNSScrip Dividend Share Reference Price
27th Feb 20267:01 amRNSInterim Dividend & Scrip Alternative
27th Feb 20267:00 amRNSCondensed Unaudited Results for FY 31 Dec 2025
26th Jan 20261:00 pmRNSPartial Bond Redemption
6th Nov 202511:04 amRNSAppointment of Joint CEOs
23rd Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:01 amRNSInterim Dividend Payment
28th Aug 20257:00 amRNSNotice of Interim Results & Prelim Interim Results
26th Jun 20251:41 pmRNSFitch investment grade credit rating maintained
23rd Jun 202512:42 pmRNSResult of AGM
23rd May 202511:45 amRNSBuy back of Shares into Treasury and TVR
15th May 20257:00 amRNSNotice of AGM
1st May 202511:30 amRNSSatisfaction of employee share awards and TVR
25th Apr 20255:35 pmRNSPulbication of Green Allocations Report
23rd Apr 202512:16 pmRNSExtension of secured bank financing
8th Apr 20253:18 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
27th Mar 20257:00 amRNSScrip Dividend Share Reference Price
25th Mar 20257:00 amRNSPublication of Annual Report and Date of AGM
21st Mar 20253:01 pmRNSS&P - revisions to credit rating and outlook
11th Mar 202511:13 amRNSInterim Dividend & Scrip Alternative
11th Mar 20257:00 amRNSCondensed Unaudited Results for FY 31 Dec 2024
18th Oct 20248:01 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSScrip Dividend Share Reference Price
16th Sep 20243:54 pmRNSHolding(s) in Company
30th Aug 20247:01 amRNSInterim Dividend & Scrip Alternative
30th Aug 20247:00 amRNSNotice of Interim Results & Prelim Interim Results
6th Aug 20244:10 pmRNSChange of Registered Office
18th Jul 20244:35 pmRNSResults of Tender Offers
11th Jul 20248:15 amRNSLaunch of Tender Offers for Bonds & Trading Updat
1st Jul 202412:01 pmRNSCredit Rating & Change of name of nomad
17th Jun 202410:18 amRNSResult of AGM
31st May 20243:03 pmRNSLogistics Sale Closing & Mandatory Bond Redemption
15th May 202410:14 amRNSNotice of AGM
7th May 202412:21 pmRNSBuyback of shares into treasury and TVR
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.